Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Lymphoid 5 Other hematologic neoplasm 4 Gastrointestinal 4 Gynecologic 2 Plasma cell 1 Other 1 CNS 1 Breast 1

Conditions

Multiple Myeloma 155 Lymphoma 20 Recurrence 17 Neoplasms 12 Hematologic Neoplasms 11 Neoplasms, Plasma Cell 9 Lymphoma, Non-Hodgkin 9 Immunoglobulin Light-chain Amyloidosis 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myelodysplastic Syndromes 5 Lymphoma, Mantle-Cell 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Smoldering Multiple Myeloma 4 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Plasma Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Breast Neoplasms 4 Ovarian Neoplasms 3 Melanoma 3 Lymphoma, B-Cell, Marginal Zone 3 Lung Neoplasms 3 Cytokine Release Syndrome 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Motor Activity × Plasma cell × 30 days × Clear all

NCT03946332 2026-05-28

PAMAL

Centre Hospitalier Universitaire, Amiens

Phase NA Terminated

Motor Activity, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡